Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07569367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum

Study acronym: ReMoTe
StatusNot Yet Recruiting
PhaseNot specified
SponsorBioSensics
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 1, 2026 to Nov 1, 2026
    • Secondary endpoints: details revised at 4 of 4 entries
    • Study description revised
    • Eligibility criteria expanded, about 5 words
  2. Secondary endpoints: details revised at 2 of 4 entries
    • Study description expanded, about 24 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
BioSensics
8 trials monitored
See 1 trial at risk
Dementia
1,978 trials monitored
See 106 trials at risk
The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with frontotemporal lobar degeneration (FTLD) syndromes. Researchers at BioSensics, Johns Hopkins University School of Medicine, and Massachusetts General Hospital will use wearable sensors, computerized speech, psychomotor, and cognitive assessments to create outcome measures and digital biomarkers for FTLD syndromes. Researchers will deploy this digital health solution to monitor 60 patients with FTLD syndromes for 24 months with study visits every 6 months.
Trial Details
NCT Number NCT07569367
Lead Sponsor BioSensics
Collaborators: Johns Hopkins University, Massachusetts General Hospital, United States Department of Defense
Conditions
(from sponsor)		 Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Corticobasal Degeneration, Corticobasal Syndrome (CBS)
Related terms Corticobasal Degeneration, Frontotemporal Dementia, Frontotemporal Lobar Degeneration
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov